Nova Eye Medical Limited (EYE.AX)
AUD 0.16
(0.0%)
AUD 0.16
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -5.97 Million AUD | 36.94% |
| 2023 | -9.48 Million AUD | -18.38% |
| 2022 | -7.88 Million AUD | -133.88% |
| 2021 | -3.66 Million AUD | 39.86% |
| 2020 | -5.74 Million AUD | 4.64% |
| 2019 | -6.01 Million AUD | -309.53% |
| 2018 | -1.46 Million AUD | -192.16% |
| 2017 | 1.51 Million AUD | -77.93% |
| 2016 | 7.55 Million AUD | 82.86% |
| 2015 | 3.94 Million AUD | 27.51% |
| 2014 | 3.09 Million AUD | 294.02% |
| 2013 | 1.72 Million AUD | -75.14% |
| 2012 | 3.14 Million AUD | 183.84% |
| 2011 | 1.11 Million AUD | -82.5% |
| 2010 | 6.36 Million AUD | 177.42% |
| 2009 | -20.73 Million AUD | -41.19% |
| 2008 | 3.91 Million AUD | -15.16% |
| 2007 | 4.61 Million AUD | 38.95% |
| 2006 | 4.99 Million AUD | 279.91% |
| 2005 | 871 Thousand AUD | -33.51% |
| 2004 | 1.31 Million AUD | -65.79% |
| 2003 | 3.82 Million AUD | -38.03% |
| 2002 | 6.17 Million AUD | 940.45% |
| 2001 | -250.72 Thousand AUD | 0.11% |
| 2000 | -736 Thousand AUD | 49.47% |
| 1999 | -1.45 Million AUD | -117.28% |
| 1998 | -670.33 Thousand AUD | -148.88% |
| 1997 | -269.33 Thousand AUD | -95.48% |
| 1996 | -137.78 Thousand AUD | 23.03% |
| 1995 | -179 Thousand AUD | 13.11% |
| 1994 | -206 Thousand AUD | 54.02% |
| 1993 | -448 Thousand AUD | 16.26% |
| 1992 | -535 Thousand AUD | -65.63% |
| 1991 | -323 Thousand AUD | 88.21% |
| 1990 | -2.73 Million AUD | 79.31% |
| 1989 | -13.23 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -1.79 Million AUD | 0.0% |
| 2024 FY | - AUD | 37.41% |
| 2024 Q2 | -4.18 Million AUD | 0.0% |
| 2023 Q2 | -5.89 Million AUD | 0.0% |
| 2023 Q4 | -3.44 Million AUD | 0.0% |
| 2023 FY | - AUD | -18.38% |
| 2022 Q2 | -3.63 Million AUD | 0.0% |
| 2022 FY | - AUD | -133.88% |
| 2022 Q4 | -4.17 Million AUD | 0.0% |
| 2021 FY | - AUD | 39.86% |
| 2021 Q4 | -2.23 Million AUD | 0.0% |
| 2021 Q2 | -1.92 Million AUD | 0.0% |
| 2020 FY | - AUD | 4.64% |
| 2020 Q2 | -2.88 Million AUD | 0.0% |
| 2020 Q4 | -2.85 Million AUD | 0.0% |
| 2019 Q2 | -4.88 Million AUD | 0.0% |
| 2019 Q4 | -780 Thousand AUD | 0.0% |
| 2019 FY | - AUD | -309.53% |
| 2018 Q4 | -1.62 Million AUD | 0.0% |
| 2018 FY | - AUD | -192.16% |
| 2018 Q2 | 154 Thousand AUD | 0.0% |
| 2017 Q4 | -2.18 Million AUD | 0.0% |
| 2017 Q2 | 3.77 Million AUD | 0.0% |
| 2017 FY | - AUD | -77.93% |
| 2016 FY | - AUD | 82.86% |
| 2016 Q2 | 4.11 Million AUD | 0.0% |
| 2016 Q4 | 3.1 Million AUD | 0.0% |
| 2015 Q2 | 2.18 Million AUD | 0.0% |
| 2015 Q4 | 1.76 Million AUD | 0.0% |
| 2015 FY | - AUD | 27.51% |
| 2014 FY | - AUD | 294.02% |
| 2014 Q2 | 1.87 Million AUD | 0.0% |
| 2014 Q4 | 1.21 Million AUD | 0.0% |
| 2013 Q4 | -234 Thousand AUD | 0.0% |
| 2013 Q2 | 1.02 Million AUD | 0.0% |
| 2013 FY | - AUD | -75.14% |
| 2012 FY | - AUD | 183.84% |
| 2012 Q4 | 754 Thousand AUD | 0.0% |
| 2012 Q3 | 754 Thousand AUD | 0.0% |
| 2012 Q1 | 288.25 Thousand AUD | 0.0% |
| 2012 Q2 | 754 Thousand AUD | 161.58% |
| 2011 Q2 | 288.25 Thousand AUD | -82.0% |
| 2011 Q1 | 1.6 Million AUD | 0.0% |
| 2011 FY | - AUD | -82.5% |
| 2011 Q4 | 288.25 Thousand AUD | 0.0% |
| 2011 Q3 | 288.25 Thousand AUD | 0.0% |
| 2010 Q4 | 1.6 Million AUD | 0.0% |
| 2010 Q3 | 1.6 Million AUD | 0.0% |
| 2010 Q2 | 1.6 Million AUD | 130.88% |
| 2010 FY | - AUD | 177.42% |
| 2010 Q1 | -5.18 Million AUD | 0.0% |
| 2009 Q3 | -5.18 Million AUD | 0.0% |
| 2009 Q2 | -5.18 Million AUD | -644.76% |
| 2009 FY | - AUD | -41.19% |
| 2009 Q1 | 952.25 Thousand AUD | 0.0% |
| 2009 Q4 | -5.18 Million AUD | 0.0% |
| 2008 Q1 | 1.12 Million AUD | 0.0% |
| 2008 Q3 | 952.25 Thousand AUD | 0.0% |
| 2008 FY | - AUD | -15.16% |
| 2008 Q4 | 952.25 Thousand AUD | 0.0% |
| 2008 Q2 | 952.25 Thousand AUD | -15.3% |
| 2007 Q2 | 1.12 Million AUD | -9.68% |
| 2007 FY | - AUD | 38.95% |
| 2007 Q4 | 1.12 Million AUD | 0.0% |
| 2007 Q3 | 1.12 Million AUD | 0.0% |
| 2007 Q1 | 1.24 Million AUD | 0.0% |
| 2006 Q2 | 1.24 Million AUD | 2255.41% |
| 2006 FY | - AUD | 279.91% |
| 2006 Q1 | -57.75 Thousand AUD | 0.0% |
| 2006 Q4 | 1.24 Million AUD | 0.0% |
| 2006 Q3 | 1.24 Million AUD | 0.0% |
| 2005 Q1 | 276 Thousand AUD | 0.0% |
| 2005 Q2 | -57.75 Thousand AUD | -120.92% |
| 2005 Q3 | -57.75 Thousand AUD | 0.0% |
| 2005 Q4 | -57.75 Thousand AUD | 0.0% |
| 2005 FY | - AUD | -33.51% |
| 2004 Q2 | 276 Thousand AUD | -79.78% |
| 2004 FY | - AUD | -65.79% |
| 2004 Q4 | 276 Thousand AUD | 0.0% |
| 2004 Q3 | 276 Thousand AUD | 0.0% |
| 2004 Q1 | 1.36 Million AUD | 0.0% |
| 2003 Q1 | 1.5 Million AUD | 0.0% |
| 2003 FY | - AUD | -38.03% |
| 2003 Q2 | 1.36 Million AUD | -9.18% |
| 2003 Q3 | 1.36 Million AUD | 0.0% |
| 2003 Q4 | 1.36 Million AUD | 0.0% |
| 2002 FY | - AUD | 940.45% |
| 2002 Q3 | 1.5 Million AUD | 0.0% |
| 2002 Q4 | 1.5 Million AUD | 0.0% |
| 2002 Q1 | -228.33 Thousand AUD | 0.0% |
| 2002 Q2 | 1.5 Million AUD | 758.36% |
| 2001 Q1 | -184 Thousand AUD | 0.0% |
| 2001 Q3 | -228.33 Thousand AUD | 0.0% |
| 2001 Q4 | -228.33 Thousand AUD | 0.0% |
| 2001 Q2 | -228.33 Thousand AUD | -24.09% |
| 2001 FY | - AUD | 0.11% |
| 2000 Q2 | -184 Thousand AUD | 49.47% |
| 2000 Q3 | -184 Thousand AUD | 0.0% |
| 2000 Q4 | -184 Thousand AUD | 0.0% |
| 2000 Q1 | -364.12 Thousand AUD | 0.0% |
| 2000 FY | - AUD | 49.47% |
| 1999 Q2 | -364.12 Thousand AUD | -117.28% |
| 1999 Q4 | -364.12 Thousand AUD | 0.0% |
| 1999 FY | - AUD | -117.28% |
| 1999 Q1 | -167.58 Thousand AUD | 0.0% |
| 1999 Q3 | -364.12 Thousand AUD | 0.0% |
| 1998 Q1 | 26.41 Thousand AUD | 0.0% |
| 1998 FY | - AUD | -148.88% |
| 1998 Q4 | -167.58 Thousand AUD | 0.0% |
| 1998 Q3 | -167.58 Thousand AUD | 0.0% |
| 1998 Q2 | -167.58 Thousand AUD | -734.38% |
| 1997 Q1 | 1883.50 AUD | 0.0% |
| 1997 Q2 | 26.41 Thousand AUD | 1302.55% |
| 1997 Q3 | 26.41 Thousand AUD | 0.0% |
| 1997 FY | - AUD | -95.48% |
| 1997 Q4 | 26.41 Thousand AUD | 0.0% |
| 1996 FY | - AUD | 23.03% |
| 1996 Q3 | 1883.50 AUD | 0.0% |
| 1996 Q1 | -13 Thousand AUD | 0.0% |
| 1996 Q2 | 1883.50 AUD | 114.49% |
| 1996 Q4 | 1883.50 AUD | 0.0% |
| 1995 Q3 | -13 Thousand AUD | 0.0% |
| 1995 Q2 | -13 Thousand AUD | -144.44% |
| 1995 Q1 | 29.25 Thousand AUD | 0.0% |
| 1995 FY | - AUD | 13.11% |
| 1995 Q4 | -13 Thousand AUD | 0.0% |
| 1994 FY | - AUD | 54.02% |
| 1994 Q3 | 29.25 Thousand AUD | 0.0% |
| 1994 Q2 | 29.25 Thousand AUD | 48.1% |
| 1994 Q1 | 19.75 Thousand AUD | 0.0% |
| 1994 Q4 | 29.25 Thousand AUD | 0.0% |
| 1993 Q2 | 19.75 Thousand AUD | -55.62% |
| 1993 Q4 | 19.75 Thousand AUD | 0.0% |
| 1993 Q3 | 19.75 Thousand AUD | 0.0% |
| 1993 FY | - AUD | 16.26% |
| 1993 Q1 | 44.5 Thousand AUD | 0.0% |
| 1992 Q1 | 80.75 Thousand AUD | 0.0% |
| 1992 Q4 | 44.5 Thousand AUD | 0.0% |
| 1992 Q2 | 44.5 Thousand AUD | -44.89% |
| 1992 Q3 | 44.5 Thousand AUD | 0.0% |
| 1992 FY | - AUD | -65.63% |
| 1991 Q4 | 80.75 Thousand AUD | 0.0% |
| 1991 Q3 | 80.75 Thousand AUD | 0.0% |
| 1991 Q1 | 165.25 Thousand AUD | 0.0% |
| 1991 Q2 | 80.75 Thousand AUD | -51.13% |
| 1991 FY | - AUD | 88.21% |
| 1990 Q4 | 165.25 Thousand AUD | 0.0% |
| 1990 Q3 | 165.25 Thousand AUD | 0.0% |
| 1990 Q1 | 271.5 Thousand AUD | 0.0% |
| 1990 FY | - AUD | 79.31% |
| 1990 Q2 | 165.25 Thousand AUD | -39.13% |
| 1989 Q2 | 271.5 Thousand AUD | 0.0% |
| 1989 Q3 | 271.5 Thousand AUD | 0.0% |
| 1989 Q4 | 271.5 Thousand AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 83.422% |
| Adherium Limited | -11.56 Million AUD | 48.299% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 18.764% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -10.243% |
| Anteris Technologies Ltd | -66.9 Million AUD | 91.063% |
| Control Bionics Limited | -5.15 Million AUD | -15.912% |
| CardieX Limited | -6.71 Million AUD | 10.919% |
| Compumedics Limited | 2.78 Million AUD | 314.378% |
| Cochlear Limited | 579.5 Million AUD | 101.032% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -71.23% |
| Cyclopharm Limited | -3.03 Million AUD | -97.008% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -185.911% |
| HeraMED Limited | -3.97 Million AUD | -50.526% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 72.662% |
| ImpediMed Limited | -22.05 Million AUD | 72.886% |
| InhaleRx Limited | -1.41 Million AUD | -322.92% |
| LBT Innovations Limited | -4.04 Million AUD | -47.666% |
| Micro-X Limited | -14.35 Million AUD | 58.337% |
| Neurotech International Limited | -8.24 Million AUD | 27.475% |
| OncoSil Medical Limited | -11.97 Million AUD | 50.076% |
| PolyNovo Limited | 5.17 Million AUD | 215.648% |
| Respiri Limited | -7.04 Million AUD | 15.19% |
| SomnoMed Limited | -2.32 Million AUD | -156.762% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 34.228% |
| Uscom Limited | -1.5 Million AUD | -296.141% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -21.589% |